Finance

Lists
Why is OCGN down 2.27%?
Dive Deeper
OCGN:NASDAQ
Ocugen Inc
US$0.95
-2.27%
(-0.022) 1D
US$0.95
-0.01% (-0.00010)
After hours
Closed: ኖቬም 10, 4:00:00 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCGN...
Open
US$0.99
High
US$1.06
Low
US$0.92
Mkt. cap
323.04 ሚ
Avg. vol.
6.90 ሚ
Volume
0.00
52-wk high
US$2.72
52-wk low
US$0.69
EPS
-US$0.30
Beta
2.04
Shares outstanding
339.31 ሚ
No. of employees
116
Open
US$0.99
High
US$1.06
Low
US$0.92
Mkt. cap
323.04 ሚ
Avg. vol.
6.90 ሚ
Volume
0.00
52-wk high
US$2.72
52-wk low
US$0.69
EPS
-US$0.30
Beta
2.04
Shares outstanding
339.31 ሚ
No. of employees
116
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
ከ6 ሰዓቶች በፊት
OCGN : 8-K : Corporate Changes & Voting Matters
News Corp
News Corp
·
ከ8 ሰዓቶች በፊት
Ocugen Inc. stock falls Tuesday, underperforms market
Investing.com India
Investing.com India
·
ከ17 ሰዓቶች በፊት
Form 8K Ocugen, Inc For: 10 November By Investing.com
Investing.com
Investing.com
·
ከ18 ሰዓቶች በፊት
Ocugen licenses gene therapy OCU400 to Celairis for Asia-Pacific
About Ocugen Inc
CEOShankar Musunuri
Employees116
Founded2013
HeadquartersMalvern, ፔንስልቬኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websiteocugen.com
Analyst ratings
Based on 5 analysts giving stock ratings to OCGN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for OCGN in the last 3 months.
Highest
Current US$0.95
US$12.00 (+1,163.16%)
Average
US$10.20 (+973.68%)
Lowest
US$8.00 (+742.11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Whitney Ijem
Canaccord Genuity
Buy
Maintained
US$11.00
+1,057.9%
11/04/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
US$10.00
+952.6%
11/05/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
US$10.00
+952.6%
09/29/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
US$12.00
+1,163.2%
09/28/2026
Michael Okunewitch
Maxim Group
Buy
Reiterated
US$8.00
+742.1%
09/16/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
US$7.00
+636.8%
05/07/2026
Elemer Piros
Lucid Capital
Buy
Maintained
US$22.00
+2,215.8%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
-193.00 ሺ
1.53 ሚ
1.49 ሚ
1.95 ሚ
Cost of goods sold
10.67 ሚ
11.26 ሚ
10.69 ሚ
12.50 ሚ
Cost of revenue
10.67 ሚ
11.26 ሚ
10.69 ሚ
12.50 ሚ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.13 ሚ
8.12 ሚ
7.24 ሚ
7.20 ሚ
Operating expense
6.13 ሚ
8.12 ሚ
7.24 ሚ
7.20 ሚ
Total operating expenses
16.80 ሚ
19.37 ሚ
17.93 ሚ
19.70 ሚ
Operating income
-17.00 ሚ
-17.84 ሚ
-16.44 ሚ
-17.75 ሚ
Other non operating income
477.00 ሺ
-150.00 ሺ
-1.97 ሚ
16.60 ሚ
EBT including unusual items
-17.71 ሚ
-19.18 ሚ
-24.88 ሚ
-3.60 ሚ
EBT excluding unusual items
-17.71 ሚ
-19.18 ሚ
-22.49 ሚ
-3.60 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.71 ሚ
-19.18 ሚ
-24.88 ሚ
-3.60 ሚ
Net profit margin
9,174.09%
-1,250.95%
-1,671.84%
-184.42%
Earnings per share
-0.06
-0.06
-0.06
-0.06
Interest and investment income
144.00 ሺ
132.00 ሺ
395.00 ሺ
649.00 ሺ
Interest expense
-1.33 ሚ
-1.32 ሚ
-4.48 ሚ
-3.09 ሚ
Net interest expenses
-1.19 ሚ
-1.19 ሚ
-4.08 ሚ
-2.44 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.40 ሚ
-17.25 ሚ
-15.86 ሚ
-17.20 ሚ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች